OMC Medical

Executive Summary

OMC Medical is a London-based regulatory affairs consultancy founded in 2015 that helps medical device, IVD, cosmetic, and pharmaceutical companies navigate complex global compliance pathways. With expertise in EU, UK, and US regulations, the firm acts as an Authorized/Responsible Person, prepares documentation, and provides quality assurance and regulatory templates. As a private, bootstrapped company with no disclosed funding, OMC Medical operates in a niche but essential segment of the healthcare value chain. Its service-oriented model generates recurring revenue through retainers and project-based engagements, though scale is limited by its small team and lack of external capital. The company's growth is tied to increasing regulatory complexity, particularly the EU's In Vitro Diagnostic Regulation (IVDR) and UKCA marking requirements, which drive demand for specialized consultancy services. However, competition from larger consultancies and potential client insourcing pose risks. Overall, OMC Medical is positioned to benefit from ongoing regulatory shifts but faces headwinds in scalability and market differentiation.

Upcoming Catalysts (preview)

• Q2 2026EU IVDR Full Implementation Deadline (May 2026) Driving Demand for IVD Regulatory Support80% success
• TBDPotential Partnership or Acquisition by Larger Regulatory Consultancy15% success
• Q4 2025UKCA Marking Deadline Extension (2025-2026) Creating Additional Compliance Work70% success